Euroscicon, United Kingdom
Thursday, 17 May 2012
Biomarkers identifying biological and physiological entities associated with disease are taking an increasingly important place at the tables of drug discovery and personalised medicine. Their discovery in biosamples requires the combined use of genomics, proteomics and bioinformatics platforms. Whilst for their application, robust techniques combining exquisite sensitivity and specificity must be developed. This conference is focused on technologies that are driving advances in this area and their application at gene and expression level in solid and fluid biosamples. As such this conference is targeted to provide leading edge information to researchers within the academic, biotechnology and pharmaceutical sectors.
|
|
Invited Speakers:
|
|
Dr Tony Warford, Warford Technology Ltd, Newmarket, Suffolk, UK Dr Peter H Bach, Director: BioPharmaLogic LLC, Cambridge. Neil Gray, Team Leader, Molecular Pathology group, AstraZeneca R&D Oncology iMed Dr David J. Britton, Proteome Sciences plc, Institute of Psychiatry, London
|
|